Found: 5
Select item for more details and to access through your institution.
Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study.
- Published in:
- European Journal of Pediatrics, 2024, v. 183, n. 5, p. 2141, doi. 10.1007/s00431-024-05446-1
- By:
- Publication type:
- Article
Letter to the Editor, regarding Li L, Zhu X, Chen X, Gao J, Ding C, et al. Advances in targeted therapy for pulmonary arterial hypertension in children. Eur J Pediatr. 2022 Dec 17.
- Published in:
- European Journal of Pediatrics, 2023, v. 182, n. 5, p. 2453, doi. 10.1007/s00431-023-04877-6
- By:
- Publication type:
- Article
Gene–Environment Correlation over Time: A Longitudinal Analysis of Polygenic Risk Scores for Schizophrenia and Major Depression in Three British Cohorts Studies.
- Published in:
- Genes, 2022, v. 13, n. 7, p. 1136, doi. 10.3390/genes13071136
- By:
- Publication type:
- Article
Polygenic risk scores for schizophrenia and major depression are associated with socio-economic indicators of adversity in two British community samples.
- Published in:
- Translational Psychiatry, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41398-022-02247-8
- By:
- Publication type:
- Article
Polygenic scores for schizophrenia and major depression are associated with psychosocial risk factors in children: evidence of gene–environment correlation.
- Published in:
- Journal of Child Psychology, 2022, v. 63, n. 10, p. 1140, doi. 10.1111/jcpp.13657
- By:
- Publication type:
- Article